Latest filing published 11 Mar 2025 for Sarepta Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Hans Lennart Rudolf Wigzell: trading record in brief
Hans Lennart Rudolf Wigzell, listed as senior executive, appears in our data through filings on Sarepta Therapeutics, Inc. shares, published by SEC (Form 4). We count 40 filings; the first trade dates from 21 June 2011 and the latest from 10 March 2025.
Every open-market trade on record is a sale: 15 sales worth €9.9M. Besides market trades, the filings include 15 share grants and 10 option exercises.
On 11 March 2025 came the latest disclosure, a share grant in Sarepta Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Hans Lennart Rudolf Wigzell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,383 sharesCommon StockSEC:0000950170-25-037526:0
- 10,500 shares@ US$124.8410.9% of flowCommon StockSEC:0000950170-24-136847:1
- 10,500 shares@ US$13.7118.9% of flowCommon StockSEC:0000950170-24-136847:0
- 3,155 shares@ US$123.853.1% of flowCommon StockSEC:0000950170-24-029536:1
- 11,745 shares@ US$123.1011.5% of flowCommon StockSEC:0000950170-24-029536:2
- 100 shares@ US$122.390.1% of flowCommon StockSEC:0000950170-24-029536:3
- 15,000 shares@ US$13.9026.3% of flowCommon StockSEC:0000950170-24-029536:0
- 1,846 shares0Common StockSEC:0000950170-24-026619:0
- 15,000 shares@ US$106.7212.8% of flowCommon StockSEC:0001209191-23-045095:1
- 15,000 shares@ US$29.0354.8% of flowCommon StockSEC:0001209191-23-045095:0
- 1,523 shares0Common StockSEC:0001209191-23-017404:0
- 2,953 shares0Common StockSEC:0001209191-22-017350:0
- 10,000 shares@ US$34.924.2% of flowCommon StockSEC:0001209191-21-019670:0
- 10,000 shares@ US$83.519.9% of flowCommon StockSEC:0001209191-21-019670:1
- 2,726 shares0Common StockSEC:0001209191-21-018423:0
- 10,000 shares@ US$34.928.1% of flowCommon StockSEC:0001209191-20-046251:0
- 9,223 shares@ US$158.9534.0% of flowCommon StockSEC:0001209191-20-046251:1
- 777 shares@ US$159.652.9% of flowCommon StockSEC:0001209191-20-046251:2
- 5,000 shares@ US$10.081.3% of flowCommon StockSEC:0001209191-20-031881:0
- 2,100 shares@ US$149.627.8% of flowCommon StockSEC:0001209191-20-031881:1
- 2,046 shares@ US$151.227.7% of flowCommon StockSEC:0001209191-20-031881:2
- 854 shares@ US$151.773.2% of flowCommon StockSEC:0001209191-20-031881:3
- 5,000 shares@ US$8.461.0% of flowCommon StockSEC:0001209191-20-017097:0
- 5,000 shares@ US$116.8914.2% of flowCommon StockSEC:0001209191-20-017097:1
- 2,075 shares0Common StockSEC:0001209191-20-014233:0
25 of 40 declarations
